Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple Helicobacter pylori proteins and enzymes" refers to a collection of molecular entities that are essential for the survival, colonization, and pathogenicity of Helicobacter pylori, a bacterium implicated in gastric ulcers, gastritis, and gastric cancer. These include enzymes such as urease (key for acid resistance in the stomach), superoxide dismutase and catalase (oxidative stress resistance), thioredoxins, various proteases, and metabolic enzymes involved in amino acid biosynthesis and central metabolism. Several core proteins (e.g., those conserved across H. pylori strains) are being explored as potential drug targets due to their essentiality and specificity to the pathogen, with the aim of developing novel therapeutics, particularly in the context of increasing antibiotic resistance. H. pylori also possesses unique proteins for metal ion trafficking (notably nickel), which are critical for enzyme function and may be leveraged for therapeutic intervention. Collectively, targeting multiple essential proteins and enzymes offers promising avenues for safe and specific eradication of H. pylori infections[2][4][5][6].
Enzyme inhibition (urease, aspartate α-decarboxylase) [4][6]; Membrane disruption (antimicrobial peptides, bacteriocins) [6]; Blocking bacterial adhesion to host tissues (e.g., by inhibiting adhesins or using specific peptides) [6]; Inhibition of nickel handling and storage (targeting nickel-binding proteins) [5]; Interference in metabolic pathways (targeting essential bacterial enzymes) [2][3][4]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Helicobacter pylori proteins and enzymes.